-
APASL 2025 Congress Chair: Dr. Lai Wei, Beijing Tsinghua Changgung Hospital
Highlights of the Congress The 34th Annual Meeting of the Asia-Pacific Association for the Study of the Liver (APASL) concluded successfully in Beijing on March 30, 2025. Under the theme…
-
EAU 2025 | Professors Dingwei Ye and Yijun Shen: Breakthrough Study on ADC Plus BCG for High-Risk NMIBC
Professor Dingwei Ye: Greetings to all readers of UroStream. I’m honored to have this opportunity to connect with Professor Yijun Shen during the EAU 2025 Confrence. As one of the…
-
EAU 2025 | 100% Specificity Achieved! Qilu Hospital of Shandong University’s “Non-Biopsy” Prostate Cancer Study Presented as Oral Report
Prostate biopsy remains the gold standard for diagnosing prostate cancer, but it carries risks such as infection, bleeding, and urinary obstruction. As a result, growing research interest has focused on developing “non-biopsy” diagnostic strategies. At the 2025 Annual Meeting of the European Association of Urology (EAU25), a study led by Professor Shouzhen Chen and Professor…
-
Professor Ying Fan Wins SGBCC Best Poster Award for Real-World Study on HER2-Positive Breast Cancer in the Neoadjuvant Setting
The 19th St. Gallen Breast Cancer Conference (SGBCC), held in Vienna from March 12 to 15, 2025, remains one of the most influential global platforms in early breast cancer care. Among seven studies awarded the prestigious Best Poster Award, four came from China, including a multi-center real-world study led by Professor Ying Fan from the…
-
EAU 2025 | CUHK’s Peter Chiu and Team Highlight Advances in Precision Biopsy and Standardized Treatment for Prostate Cancer
Prostate cancer remains one of the most prevalent malignancies threatening men’s health worldwide. A major research focus today lies in developing accurate screening and diagnostic strategies that minimize the invasiveness and psychological burden of biopsy procedures. Landmark studies like SMART and PRECISION aim to address these challenges. At the 2025 European Association of Urology (EAU)…
-
Live from the 2025 EASL Liver Cancer Summit | Studio Connection Spotlight
We’re honored to present an exclusive dialogue featuring Professor Julien Calderaro, President of the 2025 EASL Liver Cancer Summit, and Professor Jian Zhou from Zhongshan Hospital, Fudan University and the President of the Asia-Pacific Primary Liver Cancer Expert Alliance (APPLE).
-
2025 South-North Forum | Prof. Jin Feng: Breaking Barriers and Leading Innovation – A New Chapter in Breast Cancer Research
The 2025 South-North Forum – 7th Breast Cancer forum was recently held in Shanghai, co-hosted by the Shanghai Anti-Cancer Association and the China Anti-Cancer Association Committe of Breast Cancer Society(CACA-CBCS), with support from the Chinese Medical Association, Chinese Society of Oncology- Breast Oncology(CMA-CSO-BO). The event was co-organized by Fudan University Shanghai Cancer Center and The…
-
Professors Jeremy Teoh and Yige Bao Share Research Highlights and Clinical Insights, as “Chinese Excellence” Shines on Europe’s Academic Stage
With diagnostic and therapeutic technologies advancing rapidly, precision treatment strategies for genitourinary malignancies such as urothelial carcinoma and prostate cancer are evolving with growing momentum. At the recent 2025 Annual Meeting of the European Association of Urology (EAU25), Professor Jeremy Teoh of The Chinese University of Hong Kong and Professor Yige Bao of West China…
Connecting Medical Expertise through Media